Skip to main navigation
Skip to search
Skip to main content
University of Canberra Research Portal Home
Home
Profiles
Research output
Projects
Press/Media
Activities
Research units
Prizes
Student theses
Search by expertise, name or affiliation
An endothelin antagonist for resistant hypertension
Mark Naunton
Research output
:
Contribution to journal
›
Letter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'An endothelin antagonist for resistant hypertension'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Blood Pressure
100%
Randomized Trial
100%
Weber
100%
Endothelin Receptor Antagonist
100%
Antihypertensive Drugs
100%
Resistant Hypertension
100%
Treatment Goals
100%
Darusentan
100%
Endothelin Antagonist
100%
Pharmacology, Toxicology and Pharmaceutical Science
Resistant Hypertension
100%
Endothelin Receptor Antagonist
100%
Antihypertensive Drug
50%
Darusentan
50%
Neuroscience
Hypertension
100%
Endothelin Receptor Antagonist
100%
Antihypertensive Agent
50%
Darusentan
50%
Biochemistry, Genetics and Molecular Biology
Endothelin Receptor Antagonist
100%
Blood Pressure
50%